Asset Details
Do you wish to reserve the book?
Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
Do you wish to request the book?
Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
2016
Overview
Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda.
Publisher
Wolters Kluwer - Medknow,Medknow Publications and Media Pvt. Ltd,Medknow Publications & Media Pvt. Ltd,Medknow Publications & Media Pvt Ltd,Wolters Kluwer Medknow Publications
